La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Shanghai Pioneer Holding Salute del bilancio
Salute finanziaria criteri di controllo 5/6
Shanghai Pioneer Holding ha un patrimonio netto totale di CN¥1.0B e un debito totale di CN¥80.0M, che porta il suo rapporto debito/patrimonio netto a 7.9%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥1.5B e CN¥513.1M. L'EBIT di Shanghai Pioneer Holding è CN¥133.5M rendendo il suo rapporto di copertura degli interessi -86.8. Ha liquidità e investimenti a breve termine pari a CN¥114.4M.
Informazioni chiave
7.9%
Rapporto debito/patrimonio netto
CN¥79.97m
Debito
| Indice di copertura degli interessi | -86.8x |
| Contanti | CN¥114.43m |
| Patrimonio netto | CN¥1.02b |
| Totale passività | CN¥513.14m |
| Totale attività | CN¥1.53b |
Aggiornamenti recenti sulla salute finanziaria
Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?
Oct 21
Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly
Dec 15These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely
Oct 11We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt
Apr 25China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet
Dec 29
Recent updates
Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price
Jul 15Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024
Apr 24Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024
Apr 03Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings
Apr 01Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks
Mar 22Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital
Feb 26Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?
Oct 21Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024
Sep 18Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024
Sep 01Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching
Aug 09Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Apr 14Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Mar 31Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly
Dec 15China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018
Sep 21China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year
Sep 02China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward
Jun 22China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064
Apr 14China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around
Jan 16These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely
Oct 11China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year
Sep 15China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056
Sep 01China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns
Aug 26Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture
May 22We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt
Apr 25Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?
Mar 14How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?
Feb 21Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?
Feb 03Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?
Jan 16China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet
Dec 29Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?
Dec 14China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment
Nov 29Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( CN¥1.1B ) di 1345 superano le sue passività a breve termine ( CN¥442.7M ).
Passività a lungo termine: Le attività a breve termine di 1345 ( CN¥1.1B ) superano le sue passività a lungo termine ( CN¥70.4M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 1345 ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di 1345 si è ridotto da 8.7% a 7.9% negli ultimi 5 anni.
Copertura del debito: Il flusso di cassa operativo di 1345 è negativo, pertanto il debito non è ben coperto.
Copertura degli interessi: 1345 matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.